Physician profile
Howard Scott Golan
NPI 1609949619
$148,737.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $675 · 2020: $680 · 2021: $32K · 2022: $55K · 2023: $49K · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $60K · Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $59,750.00 |
| Food and Beverage | $388.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biolase, INC. | $137,203.77 | 2019-2023 | Waterlase Iplus |
| Biolase Mg LLC | $10,750.00 | 2024 | Waterlase Iplus |
| Dmg America LLC | $374.15 | 2021 | |
| Straumann USA LLC | $168.22 | 2021-2023 | |
| Geistlich Pharma, North America, INC. | $57.43 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $34.71 | 2024 | Exparel |
| Ace Surgical Supply Co., INC. | $34.07 | 2021 | |
| Kulzer, LLC | $23.29 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.95 | 2019 | |
| Voco America INC. | $15.51 | 2019 | |
| Implant Direct Sybron International LLC | $15.26 | 2019 | |
| Philips North America LLC | $15.14 | 2022 | |
| Dentsply Sirona INC | $14.22 | 2023 | Palodent Plus Ez Coat Sectional Matrix System |
| Ultradent Products INC | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Golan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.